Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 7, 2016Biology of Blood and Marrow TransplantationOpen Access

A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMichael ScordoMemorial Sloan Kettering Cancer CenterVBValkal BhattIncyte (United States)MHMeier HsuDartmouth College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Scordo et al. (2016) studied this question.

synapsesocial.com/papers/6ab3240323dc4f8dac45bb65https://doi.org/10.1016/j.bbmt.2016.09.024
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide2014 · 56 citations
  2. 2Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma2011 · 80 citations
  3. 3Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire2008 · 329 citations
  4. 4How I assess comorbidities before hematopoietic cell transplantation2013 · 216 citations
  5. 5Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach2015 · 108 citations